Limitations in the Use of [2-14C]Acetate for Measuring Gluconeogenesis In Vivo

This study was undertaken to test two assumptions critical for use of [2-14C]acetate to measure gluconeogenesis in vivo. For the assumption that incorporation into glucose of products of [14C]acetate metabolism does not affect the distribution of label within the glucose molecule, we infused [2-14C]acetate in 17 healthy subjects and [3-14C]lactate in 10 healthy subjects and compared the ratio of the resultant specific activities of plasma glucose carbons 1, 2, 5, 6, and 3, 4 obtained with each tracer. The ratio obtained with [2-14C]acetate (2.99 ± 0.07) was significantly different from the ratio obtained with [3-14C]lactate, (3.82 ± 0.2, P < 0.01). Because the model predicts that these ratios should be identical, these results indicate that either the model is incorrect or that metabolism of [14C]acetate to other compounds affects the distribution of the label within the glucose molecule. To test the assumption that plasma 3-OH-butyrate specific activity approximates the specific activity of hepatic intramitochondrial acetyl CoA, we compared the ratio of specific activities of plasma glucose and 3-OH-butyrate obtained in 7 healthy subjects infused with [2-14C]acetate and [2-14C]octanoate. The ratio obtained with [2-14C]acetate (0.18 ± 0.03) was significantly different from that obtained with [2-14C]octanoate, (0.10 ± 0.02), P < 0.001. These results suggest compartmentalization of acetyl CoA within liver mitochondria and indicate that plasma 3-OH-butyrate specific activity may not necessarily approximate intramitochondrial acetyl CoA specific activity during [2-14C]acetate infusion. We conclude that assumptions critical for use of [2-14C]acetate to measure gluconeogenesis in vivo are not valid.

[1]  J. Wahren,et al.  Noninvasive tracing of Krebs cycle metabolism in liver. , 1991, The Journal of biological chemistry.

[2]  J. Wahren,et al.  Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. , 1991, The Journal of biological chemistry.

[3]  H. Brunengraber,et al.  Nonhomogeneous labeling of liver mitochondrial acetyl-CoA. , 1991, The Journal of biological chemistry.

[4]  A. Consoli,et al.  Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. , 1990, The Journal of clinical investigation.

[5]  F. Capani,et al.  Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM , 1989, Diabetes.

[6]  B. Kalderon,et al.  A quantitative analysis of the metabolic pathways of hepatic glucose synthesis in vivo with 13C‐labeled substrates , 1987, FEBS letters.

[7]  J. Katz,et al.  Determination of gluconeogenesis in vivo with 14C-labeled substrates. , 1985, The American journal of physiology.

[8]  G. Hetényi,et al.  Correction for metabolic exchange in the calculation of the rate of gluconeogenesis in rats. , 1983, Biochemical medicine.

[9]  J. Radziuk,et al.  Calculation of the rate of gluconeogenesis from the incorporation of 14C atoms from labelled bicarbonate or acetate. , 1982, Canadian journal of physiology and pharmacology.

[10]  J. Tobin,et al.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man. , 1976, Journal of applied physiology.

[11]  W. C. Owen,et al.  Alanine and gluconeogenesis in man: effect of ethanol. , 1972, The Journal of clinical endocrinology and metabolism.

[12]  R. Rognstad,et al.  An enzymic-chemical degradation of glucose. , 1968, Analytical biochemistry.

[13]  R. Hill,et al.  ANALYTICAL PROCEDURES USING A COMBINED COMBUSTION-DIFFUSION VESSEL. SIMPLE WET-COMBUSTION METHOD SUITABLE FOR ROUTINE CARBON-14 ANALYSES , 1954 .